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Abstract 
Guided bone regeneration (GBR) is a reconstructive procedure of alveolar ridge using membranes. This procedure is 
indicated when there is no sufficient bone for implantation, or in the case of optimal implant installation for esthetic or 
functional needs. GBR can be performed before implant placement, when there is not enough bone for initial stability of 
implants and less predictable outcomes (staged approach), or performed simultaneously with implantation (combined 
approach). GBR techniques have been used for vertical and horizontal ridge augmentations with acceptable results. This 
literature review discusses the background, principles of GBR, the materials used in GBR (types of membranes and 
bone grafts), success criteria and long term results of GBR. 
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redictable formation of a direct bone-to-
implant interface is a treatment goal in 
implant dentistry. For this purpose, the 
existence of appropriate bone quality 
and quantity is necessary and important.1  
Loss of alveolar bone may occur prior to 
tooth extraction because of periodontal dis-
ease, periapical pathology, or trauma to teeth 
and bone. Damage to the bone tissues during 
tooth extraction procedures may also result in 
bone loss. Finally, alveolar bone atrophy after 
tooth extraction is a well-known phenomenon. 
Sufficient alveolar bone volume and favorable 
architecture of the alveolar ridge are essential 
to obtain ideal functional and esthetic prosthet-
ic reconstruction following implant therapy.1 
Four methods have been described to increase 
the rate of bone formation and to augment 
bone volume: osteoinduction using appropri-
ate growth factors,2 osteoconduction where a 
grafting material serves as a scaffold for new 
bone growth,3 distraction osteogenesis by 
which a fracture is surgically induced and the 
two fragments are then slowly pulled apart4 
and finally, guided bone regeneration (GBR) 
which allows spaces maintained by barrier 
membranes to be filled with new bone.5  
GBR is based on principles of guided tissue 
regeneration (GTR).6 GTR was first developed 
in the early 1980s by Nyman et al.6 This con-
cept is based on the principle that specific cells 
contribute to the formation of specific tissues.7 
Melcher described the concept of selective cell 
repopulation of defects to enhance healing.7 
Exclusion of fast-growing epithelium and con-
nective tissue from a periodontal wound for 6-
8 weeks allows the slower growing tissues in-
cluding osteoblasts, cementoblasts, and peri-
odontal ligament cells, occupy the space adja-
cent to the tooth.6,8 GBR concept employed the 
same principles of specific tissue exclusion but 
was not associated with teeth. Thus the term 
applied to this technique was guided bone re-
generation (GBR).  
Dahlin and colleagues spearheaded early 
research on GBR in an attempt to solve the 
confounding problem of reconstructing large 
osseous defects in the jaws and for the treat-
ment of the atrophic maxilla or mandible. It is 
known that to accomplish the repair of a bone 
P 
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defect, the rate of osteogenesis extending in-
ward from the adjacent bone ends must exceed 
the rate of fibrogenesis growing in from the 
surrounding muscle or connective tissue.5,9,10 
In 1988, Dahlin et al.5 published the results 
of animal experimentation on the healing of 
bone defects. Bilaterally, a through-and-
through defect was surgically created in the 
ramus of 30 Sprague-Dawley rats. On one side 
of the jaw, the defect was covered with a por-
ous polytetrafluoroethylene (PTFE) membrane 
(Gore-Tex®). The other side served as the con-
trol, without a membrane covering. After 3, 6 
and 9 weeks of healing, the specimens were 
evaluated macroscopically and histologically 
by light microscope. Statistical analysis of the 
healed sites demonstrated a highly significant 
increase in bone regeneration on the mem-
brane side as compared to the control. 
Dahlin et al.10 evaluated the principle of 
GTR to generate bone at the exposed parts of 
titanium implants. Thirty ‘‘commercially pure’’ 
10 mm titanium implants were placed in the 
tibia of 15 adult rabbits, each with three to four 
exposed threads per implant. A PTFE mem-
brane was placed over the test fixtures, cover-
ing the threads and 5 to 8 mm of the adjacent 
bone. The muscle and periosteum were re-
placed, adapted and sutured. The control fix-
tures were not covered with a membrane. Af-
ter healing periods of 6, 9 and 15 weeks, the 
specimens were removed and evaluated gross-
ly and histologically. The results showed that 
all exposed threads of the titanium implants 
were covered with newly formed bone at a 
uniform thickness, even as early as 6 weeks. 
New bone formation also was seen in the con-
trol areas, although to a much lesser extent 
than the test areas. It was shown that by plac-
ing an inert membrane with an appropriate 
pore size that hindered the penetration of un-
desirable cells, a space was created that permit-
ted the entrance of osteogenic and angiogenic 
cells from the adjacent bone marrow to popu-
late the area and proliferate. It was also recog-
nized that the amount of new bone formation 
was contingent upon the amount of space 
created by the membrane. 
Schenk et al.11 histologically demonstrated 
that bone regeneration in membrane-protected 
defects healed in a sequence of steps that simu-
lated bone formation of woven bone initially 
along new blood vasculature at the periphery 
of the defect. The new vascular supply ema-
nated from surgically created perforations in 
the cortical bone. The woven bone was subse-
quently replaced by lamellar bone, which re-
sulted in mature bone anatomy. Ultimately, 
bone remodeling occurred with the new sec-
ondary osteons being formed. 
Because the objective of GBR is to regene-
rate a single tissue namely bone, it is theoreti-
cally easier to accomplish it compared to GTR 
that requires the regeneration of bone, peri-
odontal ligament (PDL) and cementum to form 
a new periodontal apparatus.5 More than two 
decades have passed from the introduction of 
GBR into clinical practice. Today, the general 
understanding of the mechanisms leading to 
regeneration of desired tissues still agrees with 
the initially published statements.6  
 
Principles of guided bone regeneration 
To achieve better clinical outcomes, the GBR 
barrier should possess the following proper-
ties:12  
Cell exclusion: In GBR, the barrier mem-
brane is used to prevent gingival fibroblasts 
and/or epithelial cells from gaining access to 
the wound site and forming fibrous connective 
tissue.  
Tenting: The membrane is carefully fitted 
and applied in such a manner that a space is 
created beneath the membrane, completely iso-
lating the defect to be regenerated from the 
overlying soft tissue. It is important that the 
membrane be trimmed so that it extends 2 to 3 
mm beyond the margins of the defect in all di-
rections. The corners of the membrane should 
be also rounded to prevent inadvertent flap 
perforation.  
Scaffolding: This tented space initially be-
comes occupied by a fibrin clot, which serves 
as a scaffold for the in-growth of progenitor 
cells. In GBR, the cells will come from adjacent 
bone or bone marrow.  
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Stabilization: The membrane must also pro-
tect the clot from being disturbed by movement 
of the overlying flap during healing. It is there-
fore often, but not always, fixed into position 
with sutures, mini bone screws, or bone tacks. 
Sometimes, the edges of the membrane are 
simply tucked beneath the margins of the flaps 
at the time of closure, providing stabilization.  
Framework: Where necessary, as in non-
space maintaining defects such as dehiscences 
or fenestrations, the membrane must be sup-
ported to prevent collapse.  
Bone-replacement grafts are often used for 
this purpose. They serve as a sort of internal 
framework to provide a measure of support to 
the graft. Stiffer membranes such as titanium-
reinforced membranes have also been used for 
this purpose. 
Wang and Boyapati13 proposed the PASS 
principles for predictable bone regeneration in 
2006. To attain horizontal and/or vertical bone 
augmentation beyond the envelope of skeletal 
bone, four principles are needed to be met: ex-
clusion of epithelium and connective tissue, 
space maintenance, stability of the blood clot, 
and primary wound closure. 
 
Barrier membranes 
There are five criteria considered important in 
the design of barrier membranes used for 
GTR.14,15 These include biocompatibility, cell-
occlusiveness, space making, tissue integration 
and clinical manageability. Various types of 
materials have been developed, which can be 




The first membranes used experimentally by 
Nyman’s group in their initial work were con-
structed from Millipore® (cellulose acetate) 
filters. As this technique became more preva-
lent, the first commercial membrane was pro-
duced from Teflon® (e-PTFE). This membrane 
consisted of 2 parts: a collar portion, having 
open pores to allow in-growth of connective 
tissue and to prevent epithelial migration; and 
an occlusive portion, preventing the flap tis-
sues from coming into contact with the root 
surface.16 This membrane is the gold standard 
of GTR and GBR treatments.16 
PTFE is a synthetic fluoropolymer that re-
lies on an extremely strong bond between car-
bon and fluorine for its nondegradable, biolog-
ically inert properties. There is no known en-
zyme in the body capable of cleaving carbon-
fluorine bonds. Added rigidity of the material, 
PTFE, can be achieved by reinforcement with 
fluorinated ethylene propylene, resulting in 
ePTFE.17 Study by Buser et al.18 was one of the 
first to report successful ridge augmentation 
with GBR in humans using an e-PTFE mem-
brane and tenting pins. The gain in new bone 
formation ranged from 1.5 to 5.5 mm. 
Creation and maintenance of sufficient 
space underneath the barrier is an important 
factor for a successful result. Therefore, tita-
nium-reinforced polytetrafluoroethylene  
membranes (PTFE, Gore-Tex, WL Gore, Flags-
taff, AZ, USA) and titanium membranes  
(Figure 1) were introduced to increase the sta-
bility of barrier membranes 15,19,20  
Lundgren et al. compared guided bone re-
generation by PTFE membranes with titanium 
foils. The most regeneration was seen in de-
fects underneath the titanium foils, particularly 
if they had perforations. The authors suggested 
the possibility that cells and fluids necessary 
for nourishment had passed through the perfo-
rated foils and aided regeneration.21 
Since 1995, titanium membranes with mi-
croperforations (FRIOS BoneShield, Friatec, 
Mannheim, Germany) have been used for 
guided bone regeneration. The membranes are 
either triangular or oval. The mechanical prop-
erties of the membrane prevent collapse of the 
membrane and provide a constant volume un-
derneath it and areas of microporosity that are 
small enough to prevent soft tissue penetration 
through the membrane permit diffusion of in-
terstitial fluid.22 
High surface roughness of ePTFE mem-
branes facilitates adhesion of bacteria. Thus, 
primary closure over the membrane needs to 
be achieved to avoid exposure to the oral envi-
ronment and resulting bacterial colonization 
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Figure 1. Using a titanium-reinforced PTFE membrane for horizontal ridge augmentation 
 
because the resulting inflammation can im-
pair the treatment outcome. Furthermore, the 
removal of ePTFE membranes often necessi-
tates a second surgical procedure.23 For these 
reasons, Aa membrane made of high-density 
polytetrafluoroethylene (dPTFE), designed 
specially for use in socket grafting, which does 
not require primary closure, was introduced 
by Barry Bartee (Figure 2).24 For usage of this 
membrane, no primary coverage is necessary 
and there is no need for releasing incisions or 
additional freeing of the flap; thereby facilitat-
ing the surgical procedure and enhancing the  
esthetic outcome by not changing the muco-
gingival junction. In addition, because of the 
comparatively smooth surface, dPTFE mem-
branes can usually be removed without an ad-
ditional surgical procedure.23 Significant ad-
vantage of dPTFE membranes is impenetrable 
for bacteria because of its surface characteris-
tics.23 The successful use of this membrane was 
shown in animal and clinical studies.23-25 
 
Resorbable membranes 
There are two types of biologically resorbable 
membranes: 1) polyglycoside synthetic  
 
     
Figure 2. dPTFE membrane with open barrier technique 
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Figure 3. Using a collagen membrane for horizontal ridge augmentatio 
 
copolymers: polylactic acid (Guidor®), polyg-
lactide and polylactide (Resolute), polyglactin 
910 (Vicryl®); 2) collagen.17 
Collagen membranes share in common with all 
resorbable membranes the fact that they do not 
require a second surgery for retrieval. 
This saves time and cost and is greatly ap-
preciated by patients (Figure 3). Collagen is the 
principal component of connective tissue and 
provides structural support for tissues 
throughout the body.12 Properties of collagen  
membranes are mentioned below: Hemos-
tasis: Collagen is hemostatic agent and pos-
sesses the ability to stimulate platelet attach-
ment and to enhance fibrin linkage, which may 
facilitate initial clot formation and clot stabili-
zation, leading to enhanced regeneration.12  
Chemotaxis: Collagen has been shown to be 
chemotactic for fibroblasts in vitro. This prop-
erty could enhance cell migration in vivo.12  
Ease of manipulation: collagen can be easily 
manipulated and adapted.12  
Well tolerated: Collagen has been demon-
strated to be a weak immunogen and is there-
fore, well tolerated by patients. Membranes 
made of bovine collagen do not elicit an anti-
body response when used in GTR.12  
Bioresorbable: Because collagen is biore-
sorbable, during enzymatic degradation, it will 
incorporate with the flap to support new con-
nective tissue attachment.26 This may result in 
augmenting tissue/flap thickness to protect 
further bone formation.  
Slow absorption: Membranes must remain 
in place until cells capable of regeneration are 
established at the wound site. Collagen mem-
branes cross-linked with formaldehyde have 
been shown by Blumenthal27 to last 6 to 8 
weeks before being absorbed, whereas non-
cross linked membranes lose their structural 
integrity in 7 days.  
Degradation of resorbable membranes is ac-
complished by various mechanisms present 
within the periodontal tissues. The primary 
structural component of most commercially 
available collagen membranes is type I colla-
gen, which is degraded by endogenous colla-
genase into carbon dioxide and water. Cross-
linkage of collagen fibers can affect the rate of 
degradation.28 Cross-linking is a laboratory 
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modification of the collagenous matrix de-
signed to stabilize the collagen fibers and 
maintain the integrity of the membrane after 
placement.29 There are many different labora-
tory techniques for cross-linking collagen 
membranes, including ultraviolet light and 
glutaraldehyde, which increases the time pe-
riod that the device serves as an occlusive bar-
rier in vivo.29  
Cross linking of collagen membranes was 
associated with prolonged biodegradation, de-
creased tissue integration and decreased vas-
cularization.30 Clinically, the rapid degradation 
of non-cross-linked collagen membranes fol-
lowing exposure to the oral cavity has been 
reported to be an advantage in horizontal 
ridge augmentation procedures.31 
Acellular dermal matrix allograft (Allo-
DermTM) has been used in periodontal, plastic 
and reconstructive surgery since 1994. Allo-
DermTM may be used for soft tissue augmenta-
tion procedures around dental implants with-
out using the patient's own palate to procedure 
the donor tissue (Figure 4).32  
Fowler et al. in their case report preserved 
the ridge with utilizing an acellular dermal 
matrix as a barrier membrane and a deminera-
lized freeze-dried bone allograft. This report 
demonstrated an acceptable esthetic result 
with no loss of ridge height or width. Soft tis-
sue dimensions were also preserved. The two 
graft materials were well accepted by the body 
and healing was rapid and without significant 
discomfort.33 
In another study, Borges et al. compared the 
effectiveness of the acellular dermal matrix 
(ADM) as a membrane for guided bone  
regeneration (GBR), with a bioabsorbable 
membrane. In seven dogs, the mandibular pre-
molars were extracted. After 8 weeks, one bone 
defect was surgically created bilaterally and 
the GBR was performed. Each side was ran-
domly assigned to the control group (CG: bio-
absorbable membrane made of glycolide and 
lactide copolymer) or the test group (TG: ADM 
as a membrane). Post-operative healing of the 
CG was uneventful. In the TG, membrane was 
exposed in two animals and one of them was 
excluded from the sample. There were no sta-
tistically significant differences between the 
groups for any histomorphometric measure-
ment. Clinically, both groups showed an in-
crease in the thickness of keratinized tissue 
and a reduction in the width of keratinized tis-
sue. Radiographically, an image suggestive of 
new bone formation could be observed in both 
groups at 8 and 16 weeks following GBR.34 
The use of Alloderm has several advantages 
because it does not contain cellular material, 
which eliminates the possibility of rejection 
because of the presence of major histocompati-
bility complex class I and II antigens. In addi-
tion, the unlimited supply, color match, and 
thickness, as well as no degradation if primary 
closure is not achieved, and formation of addi-
tional attached gingival makes this material a 
good choice for membrane barrier techniques. 
Oh et al. compared two collagen mem-
branes, Bio-Gide ® and BioMend ExtendTM, 
for the treatment of implant dehiscence defects 
in eight mongrel dogs.35 The results of this 
study indicated that: (1) GBR treatment with  
 
  
Figure 4. Using Alloderm for GBR without primary closure 
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collagen membranes may significantly enhance 
bone regeneration, manifested at late stage  
(16 weeks) of healing; and (2) space mainten-
ance and membrane coverage were the two 
most important factors affecting GBR using 
bioabsorbable collagen membranes. 
Synthetic polymers can be prepared repro-
ducibly under strictly controlled conditions 
and can be made available in almost unlimited 
quantities, which are clear advantages  
over collagen. Another advantage is the ability 
of these polymers to completely biodegrade to 
carbon dioxide and water via the Krebs cycle.17 
Synthetic polymers used as barrier membrane 
materials are polyglycolides (PGAs), polylac-
tides (PLAs), or copolymers. Polydioxanones 
and trimethylene carbonates are also used.17 
The early tissue reactions to PLA mem-
branes were analyzed by Piattelli et al. in an 
experimental study in the rabbit tibia. After 3 
weeks, the membrane started to show signs of 
degradation. In some areas, bone was in direct 
contact with the membrane surface, while in 
other portions a small layer of multinucleated 
giant cells was interposed between the bone 
and the membrane.36  
In another study, Von et al. exhibited fibr-
ous encapsulation on both sides of the PLA 
membrane, with minimal signs of cell infiltra-
tion.37 Simion et al. studied premature expo-
sure of PLA/PGA membranes to the oral cavi-
ty. After exposure, these membranes started to 
resorb and after 3-4 weeks, the resorption 
process was completed. Simion et al. regarded 
this characteristic behavior as an advantage 
over nonresorbable barriers because it could 
lead to spontaneous healing and closure of the 
tissue.38  
Guidor (PLA) was the first resorbable bar-
rier to be approved by the Food and Drug 
Administration (FDA) for membrane tech-
niques. The resorption process of the material 
is programmed to ensure barrier function for a 
minimum of 6 weeks, after which it slowly re-
sorbs. Complete resorption occurs at approx-
imately 12 months.39 
Platelet-rich plasma (PRP) is not a barrier 
membrane. Barrier membranes prevent soft 
tissue from invading the bone graft site for at 
least several weeks or months. PRP does not 
prevent fibroblasts from invading a bone graft 
site over a long time. Therefore, we must not 
use PRP as a membrane.40  
 
GBR with bone grafting 
Various methods have been developed to pre-
vent membrane collapse and to preserve and 
maintain the space. Placing various bone graft 
materials under the membrane or using me-
chanical support are among the methods used. 
Grafts are generally classified according to 
their original source as follows: autograft (oral 
or extraoral), allograft (DFDBA, FDBA, Puros 
cancellous), xenograft (bovine or porcine), and 
alloplasts (hydroxyapatite, calcium phos-
phate).41-44  
 
Autogenous bone grafts 
Autogenous bone is derived from the individ-
ual for whom the graft is intended. It has long 
been considered the gold standard of bone 
graft materials. Autogenous bone grafts form 
bone by the processes of osteogenesis, osteoin-
duction, and osteoconduction. It consists of 
two components. The first is a natural anatom-
ical structure for scaffolding cellular invasion 
and for graft and host site support. The second 
offers a component of primarily type I collagen 




Allografts are tissues taken from individuals of 
the same species as the hosts. There are three 
main divisions: (1) frozen, (2) freeze-dried, and 
(3) freeze-dried demineralized. They come in 
different forms such as particulate, gels and 
putties. A major advantage of their use is that 
the material is readily available without the 
requirement of a secondary surgical site. They 
provide a source of type I collagen, which is 
the sole organic component of bone. However, 
they do not produce the inorganic calcium or 
scaffolding necessary for bone regeneration. 
Allograft bone must be processed to guarantee 
safety.45,46 
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Alloplasts 
Alloplasts are synthetic. They contribute to the  
repair of osseous defects and to the enhance-
ment of osseous ingrowth. 
The chemical composition, physical form, 
and differences in surface configuration result 
in varying levels of bioresorbability. The vary-
ing nature of available commercial graft mate-
rials (porosity, geometries, differing solubili-
ties and densities) will determine the resorp-




Xenografts are derived from other species. 
They are materials with their organic compo-
nents totally removed. With their removal, 
concern about immunological reactions be-
comes nonexistent. The remaining inorganic 
structure provides a natural architectural ma-
trix as well as an excellent source of calcium.48 
The inorganic material also maintains the 
physical dimension of the augmentation dur-
ing the remodeling phases.49 
 
Recombinant bone morphogenetic proteins 
(BMP) and tissue-derived growth factors 
As a result of research on the use of recombi-
nant bone morphogenetic proteins (BMP) and 
tissue-derived growth factors for osseous re-
generation, these materials have been posi-
tioned as the definitive answer for future os-
seous regeneration. BMPs are osteoinductive 
compounds that encourage new bone forma-
tion. At least seven structurally unique BMPs 
have been identified that can induce bone for-
mation as well as accelerate the process of 
bone regeneration. BMPs act as a signal in in-
itiating and regulating specific tissue forma-
tion.50 This activity leads to a series of deve-
lopmental processes that include chemotaxis, 
proliferation, and differentiation, which result 
in the transient formation of cartilage (endo-
chondral bone formation) and the production 
of living bone tissue. At this time, both the 
technology and the production of the material 
are quite expensive.50 
Scientists and clinicians have long recognized  
the importance of collagen as a biomaterial be-
cause of its singular role as a major component of 
bone. The primary function of collagen is to act 
as tracks on which cells can move. Whereas col-
lagen influences the cellular processes, the hy-
droxylapatite provides the structural and mor-
phological support required for cell attachment.51 
Detailed analyses have revealed that a 15-
residue amino acid sequence within a chain of 
type I collagen is responsible for its cell-
binding functions. This discovery led to the 
isolation and production of a synthetic materi-
al called P-15. As a first step, to mimic the phy-
siological nature of bone, a composite of P-15 
and natural inorganic bone mineral (ABM) was 
examined. ABM/P-15 is a synthetic, collagen-
like agent that imitates autogenous bone.51,52 
This material, PepGen P-15 (CeraMed, 
Lakewood, Colo), provides a tissue-engineered 
hospitable biomimetic habitat for cells and 
serves as a bonelike substitute for autogenous 
bone grafts. In clinical studies, PepGen P-15 
demonstrated an increased expression of 
growth factors TGF, the agents associated with 
osteodifferentiation. PepGen P-15 has been 
demonstrated and clinically shown to have 
predictable benefits over other currently mar-
keted bone graft replacement materials.51,52 
 
Properties of graft granules 
A number of studies have demonstrated that 
osseointegration and osteoconduction 
processes are influenced by physical and 
chemical properties of the material, including 
granule size, granule morphology, crystallinity 
and porosity, surface roughness, and ratio of 
calcium to phosphate (Ca:P) in the composi-
tion. Nevertheless, the requirements the best 
performance for these biomaterials have not 
been thoroughly addressed.53 
Misiek et al. compared sharp-edged and 
rounded Hydroxyapatite (HA) granules and 
observed that although a mild inflammatory 
response was seen at the implant sites with both 
particle shapes, inflammation resolved faster in 
sites implanted with rounded granules.54  
Yang et al.55 stated that the dissolution and 
crystallinity of HAs were related in a negative 
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manner in vitro. The Ca:P ratio in the composi-
tion of HAs seems to directly affect crystallini-
ty. Thus, highly crystalline HA—Ca10 (PO4) 
6(OH)2—has a Ca:P molar ratio of 1.67, whe-
reas less crystalline bioceramics, such as trical-
cium phosphate and tetracalcium phosphate, 
are characterized by lower or higher ratios of 
1.50 and 2.0, respectively.56 
Takeshita et al.57 observed that nonporous 
HA granules grafted into bone defects sur-
rounding titanium implants resulted in fibrous 
encapsulation during the early healing stages. 
Deligianni et al.58 used a bone marrow cell-
culture model to demonstrate that cell adhe-
sion, proliferation, and detachment strength 
increased as the roughness of HA increased. 
Oonishi et al,59 evaluated HA with granules 
of 1 to 3 lm, 10 lm, and 100 to 300 lm in diame-
ter and noticed that a minimal size of 10 lm 
was necessary to enable a direct contact be-
tween bone and the particles. Sun et al,60 stu-
died the effect of different sizes of HA granules 
(from 0.5 to 841 lm) in osteoblast cultures and 
reported inhibitory effects for the 0.5 to 3 lm 
group. Kuroda61 evaluated bone defects filled 
with HA granules of 100 to 2000 lm and ob-
served improved osteoconductive activity in 
the group with granules of 100 to 300 lm. 
Based on the results of the Carvalho et al.’s 
study,53 the scaffold structure and surface 
roughness, rather than the granule size itself, 
accounted for improved bone formation.  
 
Horizontal and vertical ridge augmentation 
with GBR 
A variety of surgical techniques and materials 
have been described to established a sufficient 
bony structure for supporting dental implants, 
including block graft augmentation, GBR, 
ridge splitting and horizontal distraction os-
teogenesis. 
The first techniques used for horizontal 
ridge augmentation were extraoral bone block 
grafts and then intraoral bone block grafts. 
With introduction of GBR technique, combina-
tion of block grafts with bone fillers and mem-
branes was applied. The first membrane used 
for horizontal ridge augmentation was ePTFE, 
but because of the increased risk of complica-
tions following wound dehiscence, resorbable 
collagen membrane introduced.62 
The first researches about vertical ridge 
augmentation were animal studies in the 
1990s. In the most studies, the results were sig-
nificant.62 In 1994, Simion et al. reported the 
first human and histologic study of vertical 
bone regeneration of the atrophic edentulous 
ridge with the GBR technique. The results 
showed that vertical bone regeneration was 
possible to an extent of 4 mm in height. The 
implant to bone contact was reported approx-
imately 42% in this study.63 
Tinti et al. performed a clinical study in this 
subject. They used autogenous bone chips and 
ePTFE membranes. Vertical ridge augmenta-
tion in this study was significant and the per-
centage of bone to implant contact was re-
ported 39.1% to 63.2%.64  
Esposito et al.65 (2006) in a systematic re-
view reported that both guided bone regenera-
tion procedures and distraction osteogenesis 
can be used to augment bone vertically, but it 
is unclear which is the most efficient. It is un-
clear whether augmentation procedures are 
needed at immediate single implants placed in 
fresh extraction sockets; however, sites treated 
with barrier + Bio-Oss showed a higher posi-
tion of the gingival margin than sites treated 
with barriers alone. More bone was regene-
rated around fenestrated implants with nonre-
sorbable barriers than without barriers; how-
ever, it remains unclear whether such bone is 
of benefit to the patient. Bone morphogenetic-
proteins may enhance bone formation around 
implants grafted with Bio-Oss, but there was 
no reliable evidence supporting the efficacy of 
other active agents, such as platelet-rich plas-
ma, in conjunction with implant treatment. 
Aghaloo and Moy62 in a systematic review 
reported that the greatest implant survival rate 
(95.5%) was found for the GBR technique. In 
this study, the results of all techniques used for 
horizontal ridge augmentation were evaluated. 
Esposito et al.66 in another systematic review 
in 2009, evaluated 13 RCTs (Three RCTs (106 
patients) dealt with horizontal and 10 trials 
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(218 patients) with vertical augmentation) 
which were suitable for inclusion. When com-
paring whether vertical augmentation proce-
dures were more advantageous than short im-
plants, a meta-analysis of two trials resulted in 
higher implant failures and statistically signifi-
cantly more complications in the vertically 
augmented group. When various horizontal 
augmentation techniques (three trials) were 
compared, no statistically significant differenc-
es were observed. When various vertical bone 
augmentation techniques (eight trials) were 
compared, no statistically significant differenc-
es were observed except for three trials which 
showed that more vertical bone gain could be 
obtained with osteodistraction than with inlay 
autogenous grafts, and with bone substitutes 
rather than autogenous bone in guided bone 
regeneration in posterior atrophic mandibles, 
and that patients preferred a bone substitute 
block over a block of autogenous bone taken 
from the iliac crest. 
 
Factors influencing the success of GBR 
Factors that have been suggested to influence 
the outcome of GBR include patient factors 
(e.g., smoking), excessive swelling, passive flap 
tension, cortical penetration, defect morpholo-
gy, defect length and defect angle, membrane 
fixation, and materials used.67 
It was suggested that small to moderate ho-
rizontal bone loss of 3 to 6 mm in the HVC (ho-
rizontal, vertical and combination) 
classification68 or division B (barely sufficient) 
bone, if the ridge width (2.5 to 5.0 mm) is barely 
sufficient for 4.0 mm diameter dental implants, 
is a good indication for GBR treatment.69 
Park et al.67 evaluated the morphology of 
the ridge on the outcomes of GBR. In this 
study, they reported that ridge width did not 
have a significant effect on the regenerative 
outcome and cross-sectional pre-surgical ridge 
angles may have prognostic value in estimat-
ing the outcome of simultaneous GBR. At 6 
months, a ridge angle < 28° resulted in a statis-
tically significantly greater percentage of defect 
height reduction than a ridge angle > 28°.  
Due to an avascular zone located over the  
edentulous ridge about 1 to 2 mm wide, it may 
be inferred that mid-crestal incisions on the 
edentulous ridge with a possible vertical inci-
sion on the mesial aspect of the flap seem to 
yield the most anatomic potential for success.70 
Clinical human studies reported less edema, 
inflammation, and pain with a crestal incision 
compared to a vestibular or mucobuccal fold 
incision. This may minimize flap necrosis and 
further reduce the risk for membrane expo-
sure.67 Flap advancement is required as part of 
certain surgical procedures (e.g., ridge aug-
mentation) to attain tension-free primary clo-
sure along the incision line.71 
Romanos72 in an article about periosteal re-
leasing incision discussed surgical guide for 
this procedure which is mentioned below: 
1. The flap has to be a mucoperiosteal flap, 
and must be raised sufficiently over the muco-
gingival junction in an apical direction for at 
least 10 mm. 
2. With conventional dental forceps (surgic-
al forceps may lead to flap perforations) 
hold (but do not pull) the flap in a coronal 
direction to evaluate the tension during cover-
age of the augmentation site. 
3. With a new scalpel (blade no. 15 or 15c), 
start at the distal part of the flap periosteum 
and, without stopping (that is in one shot), cut 
the periosteum in a depth of 1–3 mm always 
moving the blade in a direction from distal to 
mesial. 
4. The blade should cut the tissue in a level 
apical to the mucogingival junction. To avoid 
flap perforation, do not cut the area of the ke-
ratinized mucosa. 
5. Pull and evaluate (in a coronal direction) 
the flap and check for a tension-free flap ad-
vancement. In case of insufficient closure, stay 
at the same area and cut more deeply in the 
muscle layer or use a new PRI in a parallel di-
rection to the previous one, more apically. 
6. Always check the final result in such a 
way that the buccal flap margin covers the lin-
gual or palatal site at least for 3–5 mm. If this 
overlapping does not occur, there is a lot of 
tension in the flap, which means the closure is 
insufficient. Muscle release can be performed 
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using dissection scissors. This is very impor-
tant, especially in vertical or horizontal aug-
mentations of the alveolar ridge with cortico-
cancellous bone grafts or advanced applica-
tions of the GBR-technique to avoid graft ex-
posure. 
Reported methods to alleviate tension over 
the suture line include overlapping the flap, po-
sitioning the flap laterally, tissue grafting, or 
using a combination of mattress sutures and 
interrupted sutures.73 Despite these surgical 
techniques, this procedure may still be asso-
ciated with excessive tension on the suture line, 
which can often result in suture line opening 
and early membrane exposure and infection.73 
For these reasons, Kfir et al.73 introduced mini-
mally invasive guided bone regeneration. In 
this technique, a vertical incision is made mesial 
to the augmentation zone. The periosteum is 
initially elevated with a miniature chisel, and 
then through a series of sequential balloon infla-
tions. This yields a tunnel with adequate space 
for membrane insertion, decortication, and 
grafting with substitute bone and platelet rich 
fibrin (PRF) filling. Primary closure is obtained 
by 2 or 3 simple interrupted sutures.Another 
factor that can affect the results of GBR is decor-
tications (Figure 5). Decortication of bone prior 
to placing a bone graft is often performed as 
part of a GBR procedure. It is the intentional 
drilling of holes through the cortical bone into 
the cancellous bone or the removal of cortical 
bone to expose cancellous bone.76 
Decortication is done ostensibly to enhance 
the healing process by promoting bleeding and 
allowing progenitor cells and blood vessels to 
reach a bone-grafted site more readily. In addi-
tion, decortication may improve the physical 
bond between grafted bone and a recipient 
site.74,75 
Nishimura et al.76 evaluated the Effects of 
cortical bone perforation on experimental 
guided bone regeneration in rabbits. Newly 
formed bone volume and ALP expression in 
Group B (Corticalm perforation size: 3×15 mm) 
were more extensive than those in Group A 
(Corticalm perforation size: 1×15 mm ) at 6 
weeks. Histomorphometric analysis showed 
significant differences between both groups. 
The authors concluded that a larger perfora-
tion was associated with prompter bone for-
mation in the secluded space during GBR. 
However, there is controversy in the dental 
literature with respect to the usefulness of this 
procedure because its ability to accelerate or 
increase bone regeneration has not been subs-
tantiated in human clinical trials, and there 




Figure 5. Cortical perforation 
 
Decortication can have some minor nega-
tive consequences such as increased operative 
time, additional blood loss, potentially greater 
postoperative pain, and some bone loss if the 
GBR procedure fails.76 
 
Success of GBR 
The success of GBR is one of the important 
parts of implant dentistry. Is success to be de-
fined merely as covering of a dehisced or fene-
strated implant surface with regenerated hard 
tissues, or the ability to place an implant in re-
generated bone without generating a fenestra-
tion or dehiscence?  
The first generation definition of success 
was proposed by Mellonig and Triplet.77 This 
definition was the ability of completely cover a 
dehisced or fenestrated implant surface with 
regenerated hard tissue. 
The second-generation definition of success 
was the regeneration of a sufficient dimension 
of bone to withstand functional forces over 
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time.78 However, regeneration of bone to cover 
an exposed implant surface, or regeneration of 
covering bone of sufficient thickness to with-
stand function forces over time are no longer 
adequate definitions of success following GBR 
therapy. In the esthetic zone, any definition of 
success must include regeneration or prepa-
thologic alveolar ridge morphology, to ideally 
support the covering soft tissues and help 
maximize treatment outcomes. Such a defini-
tion represents the third –generation definition 
of success of GBR.78 
 
Long term results of GBR 
One question that must be answered is the 
prognosis of an implant placed in augmented 
ridge compared to native bone. Survival rate of 
implants placed into sites with regenerated 
bone using barrier membranes have been re-
ported to vary between 79% and 100% with 
majority of studies indicating more than 90% 
after at least 1 year of function.79-82  
For the first time, Fugazzotto83 published an 
article on this subject in 1997. In this paper, 
failure and success rates of 626 implants either 
placed in regenerated alveolar bone or treated 
with guided bone regeneration to rebuild bone 
over implant fenestrations or dehiscences were 
evaluated. The cumulative success rate of im-
plants in function in regenerated bone for 6-51 
months was 93.8%. 
Fugazzotto84 Published another paper in 
this topic and reported the cumulative success 
rate of implants in function in regenerated 
bone for 72-133 months, was about 97.3%. 
Simion et al.85 evaluated the success rate of 
123 implants inserted in vertically augmented 
ridges during 1-5 years of prosthetic loading. 
The overall success rate of 97.5% was reported 
according to the success criteria listed.86 
In a 5-year prospective controlled study, 
implants placed into pristine bone were com-
pared with implants associated with bone re-
generation. No significant differences were 
found regarding the cumulative implant sur-
vival rates in the three groups: sites aug-
mented with a collagen membrane and a de-
proteinized bovine bone mineral (95.4%), sites 
augmented with an e-PTFE membrane and a 
deproteinized bovine bone mineral (92.6%), 
and sites without augmentation (97.3%).87 
Another study providing controls reported 
38 implants in seven patients. In this study, 21 
implants were placed in conjunction with GBR 
and 17 could be placed into the host bone 
without the need for regeneration therapy. A 
polylactic, polyglycolic acid membrane was 
used in all regenerated sites. After an average 
of 25 months following incorporation of fixed 
reconstructions, a 100% survival rate was 
found for both test and control implants and 
no significant difference in marginal bone le-
vels was recorded between the two groups.81 
Although the data are derived from a small 
number of studies showing an adequate de-
sign, survival rates have been documented 
similar to the ones generally reported for im-
plants placed conventionally into sites without 
the need for bone augmentation. 
Conclusion 
Presently available data demonstrates GBR 
therapy to be a predictable and successful pro-
cedure to augment bone in a horizontal direc-
tion at sites exhibiting insufficient bone volume 
for implant placement under standard condi-
tions. Among the techniques introduced for ver-
tical ridge augmentation, GBR is a successful 
technique, although distraction osteogenesis 
allows for more vertical bone augmentation 
than other techniques. For horizontal ridge 
augmentation, resorbable membranes have suc-
cessful and predictable results the same as non-
resorbable membranes. Long-term results 
showed that survival rates of implants placed in 
augmented bone is high and comparable with 
implants placed in native bone. 
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